2.095
price up icon2.70%   0.055
after-market Handel nachbörslich: 2.09 -0.005 -0.24%
loading

Finanzdaten der Immix Biopharma Inc-Aktie (IMMX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.99%
5.5901
5.3759 4.5238 3.7207 2.5208
Operating Income/Loss
3.99%
-5.5901
-5.3759 -4.5238 -3.7207 -2.5208
Nonoperating Income/Loss
0.2679
- - 0.1288 0.0279
Income/Loss From Continuing Operations Before Tax
3.40%
-5.3222
-5.1473 -4.3371 -3.5919 -2.4929
Income Tax Expense/Benefit
9.27%
0.00884
0.00809 0.00681 0.00635 0.00517
Income/Loss From Continuing Operations After Tax
3.41%
-5.3311
-5.1554 -4.3439 -3.5982 -2.498
Net Income/Loss
3.41%
-5.3311
-5.1554 -4.3439 -3.5982 -2.498
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
9.43%
-0.0721
-0.0659 -0.0632 - -
Basic Average Shares
1,484%
23.44
1.48 18.58 15.04 13.90
Diluted Average Shares
1,484%
23.44
1.48 18.58 15.04 -0.5706
Basic Earnings Per Share
8.33%
-0.22
-0.24 -0.23 -0.24 -0.18
Diluted Earnings Per Share
8.33%
-0.22
-0.24 -0.23 -0.24 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$72.30
price down icon 0.47%
$21.48
price up icon 2.63%
$32.89
price up icon 1.26%
$27.90
price up icon 13.09%
$104.94
price up icon 2.45%
biotechnology ONC
$255.77
price up icon 0.05%
Kapitalisierung:     |  Volumen (24h):